Additional file 2 of Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients

dataset

posted on 2024-11-14, 04:41 authored by Xiuli Zhang, S. Peter Goedegebuure, Michael Y. Chen, Rashmi Mishra, Felicia Zhang, Yik Yeung Yu, Kartik Singhal, Lijin Li, Feng Gao, Nancy B. Myers, Tammi Vickery, Jasreet Hundal, Michael D. McLellan, Mark A. Sturmoski, Samuel W. Kim, Ina Chen, Jesse T. Davidson, Narendra V. Sankpal, Stephanie Myles, Rama Suresh, Cynthia X. Ma, Ademuyiwa Foluso, Andrea Wang-Gillam, Sherri Davies, Ian S. Hagemann, Elaine R. Mardis, Obi Griffith, Malachi Griffith, Christopher A. Miller, Ted H. Hansen, Timothy P. Fleming, Robert D. Schreiber, William E. Gillanders

Additional file 2: Supplementary tables (excel): include 3 supplementary tables with legends.

Funding

National Cancer Institute Centene Corporation Susan G. Komen for the Cure Alvin J. Siteman Cancer Center National Institute of Health Foundation for Barnes-Jewish Hospital

History

Related Materials

1.
DOI - Is supplement to Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients

Additional file 2 of Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients

Funding

National Cancer Institute Centene Corporation Susan G. Komen for the Cure Alvin J. Siteman Cancer Center National Institute of Health Foundation for Barnes-Jewish Hospital

History

Related Materials

Usage metrics

Categories

Keywords

Licence

Exports